News that NFL legend Deion Sanders is recovering after a battle with bladder cancer has sparked an important conversation ...

Deion Sanders opened up about his bladder cancer diagnosis, raising awareness on symptoms, risk factors, and the importance ...

FDA grants priority review to TAR-200, which demonstrated an 82% complete response in high-risk bladder cancer unresponsive ...

Facing a 'very high-risk' tumor, Hall-of-Famer receives top care, including a new bladder, from Janet Kukreja, MD, and CU ...

Patients with high-risk bladder cancer reported similar quality of life when treated with sasanlimab plus BCG versus BCG alone, new study data showed.

An expert discusses how real-world evidence is driving gene therapy adoption in BCG-unresponsive disease primarily through ...

Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) granted Priority Review to the ...

An expert discusses how integrating newer NMIBC therapies faces operational barriers including administration logistics, staff training and formulary restrictions, while solutions require better ...

Market OverviewThe global Cancer Immunotherapy Market is valued at USD 121.4 Billion in 2024 and is projected to reach a ...

The FDA prioritizes TAR-200 for treating high-risk bladder cancer, showcasing promising phase 2b study results and innovative ...

Raritan, New Jersey Friday, July 18, 2025, 15:00 Hrs [IST] ...